Trials / Completed
CompletedNCT02986074
CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming Strategies
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study will compare therapeutic efficacy of a novel spinal cord stimulation leads implant based on anatomical landmarks with standard surgical implantation technique.
Detailed description
The primary purpose of this study is to compare the therapeutic efficacy of the conventional, paresthesia mapping-based burst spinal cord stimulation (SCS) implantation strategy to a more novel, anatomic midline-based approach that has the potential to streamline the workflow associated with the SCS treatment continuum.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Paresthesia mapping lead evaluation first | Subjects will evaluate the clinical efficacy of stimulation delivered using the lead implanted using paresthesia mapping in the first part of the SCS trial and using the lead implanted using anatomical midline placement in the second part of the SCS trial |
| DEVICE | Anatomical midline lead evaluation first | Subjects will evaluate the clinical efficacy of stimulation delivered using the lead implanted using anatomical midline in the first part of the SCS trial and using the lead implanted using paresthesia mapping placement in the second part of the SCS trial |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2019-08-19
- Completion
- 2019-08-19
- First posted
- 2016-12-08
- Last updated
- 2021-05-03
- Results posted
- 2021-05-03
Locations
2 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02986074. Inclusion in this directory is not an endorsement.